Predictive value of direct nitrate reductase assay and its clinical performance in the detection of multi- and extensively drug-resistant tuberculosis

References

1. Affolabi D., Odoun M., Martin A., Palomino J. C., Anagonou S., Portaels F. 2007; Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin. J Clin Microbiol 45:2123–2125 [View Article][PubMed]
   [Google Scholar]
2. Angeby K. A., Klintz L., Hoffner S. E. 2002; Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 40:553–555 [View Article][PubMed]
   [Google Scholar]
3. Becton Dickinson and Company 2005; BD BACTEC MGIT 960 SIRE kit for the antimycobacterial susceptibility testing of Mycobacterium tuberculosis. http://www.bd.com/ds/technicalCenter/clsi/clsi-960sire.pdf
4. Coban A. Y., Birinci A., Ekinci B., Durupinar B. 2004; Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int J Antimicrob Agents 24:304–306 [View Article][PubMed]
   [Google Scholar]
5. Heifets L. B. 1991; Drug susceptibility test in the management of chemotherapy of tuberculosis. In Drug Susceptibility in the Chemotherapy of Mycobacterial Infections pp. 89–121 Edited by Heifets L. B. Boca Raton: CRC Press;
   [Google Scholar]
6. Imperiale B. R., Cataldi A. A., Morcillo N. S. 2011; Rapid detection of multidrug-resistant Mycobacterium tuberculosis by multiplex allele-specific polymerase chain reaction. Int J Tuberc Lung Dis 15:496–501 [View Article][PubMed]
   [Google Scholar]
7. Imperiale B. R., Zumárraga M. J., Weltman G., Zudiker R., Cataldi A. A., Morcillo N. S. 2012; First evaluation in Argentina of the GenoType® MTBDRplus assay for multidrug-resistant Mycobacterium tuberculosis detection from clinical isolates and specimens. Rev Argent Microbiol 44:283–289[PubMed]
   [Google Scholar]
8. Imperiale B. R., Zumárraga M. J., Di Giulio A. B., Cataldi A. A., Morcillo N. S. 2013; Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. Int J Tuberc Lung Dis 17:1088–1093 [View Article][PubMed]
   [Google Scholar]
9. Martin A., Panaiotov S., Portaels F., Hoffner S., Palomino J. C., Angeby K. 2008; The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 62:56–64 [View Article][PubMed]
   [Google Scholar]
10. Martin A., Imperiale B., Ravolonandriana P., Yilmaz Coban A., Akgunes A., Ikram A., Satti L., Odoun M., Pandey P.& other authors ( 2014; Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis. J Antimicrob Chemother 69:441–444 [View Article][PubMed]
    [Google Scholar]
11. Ministry of Health 2011) Tuberculosis situation in Argentina. Epidemiological Bulletin http://msal.gov.ar/htm/site/sala_situacion/PANELES/BEP46-web/BEP46_TBC_int.pdf
    [Google Scholar]
12. Morcillo N., Imperiale B., Palomino J. C. 2008; New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice. Infect Drug Resist 1:21–26 [View Article][PubMed]
    [Google Scholar]
13. Morcillo N., Imperiale B., Di Giulio B. 2010; Evaluation of MGIT 960 and the colorimetric-based method for tuberculosis drug susceptibility testing. Int J Tuberc Lung Dis 14:1169–1175[PubMed]
    [Google Scholar]
14. Musa H. R., Ambroggi M., Souto A., Angeby K. A. 2005; Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J Clin Microbiol 43:3159–3161 [View Article][PubMed]
    [Google Scholar]
15. National Institute of Infectious Diseases 2010 XL Annual meeting of the Confederal Council of Tuberculosis Dr Carlos Malbrán, Buenos Aires, Argentina, November 24–25 2010
    [Google Scholar]
16. Richter E., Rüsch-Gerdes S., Hillemann D. 2006; Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures. J Clin Microbiol 44:1769–1775 [View Article][PubMed]
    [Google Scholar]
17. Rüsch-Gerdes S., Pfyffer G. E., Casal M., Chadwick M., Siddiqi S. 2006; Multicenter laboratory validation of susceptibility testing of the BACTEC MGIT 960 technology for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 44:688–692 [View Article][PubMed]
    [Google Scholar]
18. Sharma B., Pal N., Malhotra B., Vyas L. 2010; Evaluation of a rapid differentiation test for Mycobacterium tuberculosis from other Mycobacteria by selective inhibition with p-nitrobenzoic acid using MGIT 960. J Lab Physicians 2:89–92 [View Article][PubMed]
    [Google Scholar]
19. Tuberculosis Control Program of Buenos Aires Province 2012 Epidemiological report, year 2010. Ministry of Health La Plata, August 2012
    [Google Scholar]
20. WHO 2008 Anti-tuberculosis Drug Resistance in the World. Fourth Global Report WHO/HTM/TB/2008.394 http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
    [Google Scholar]
21. WHO 2009 Global Tuberculosis Control. Epidemiology, Strategy, Financing WHO/HTM/TB/2009.411 http://whqlibdoc.who.int/publications/2009/9789241563802_eng_doc.pdf
    [Google Scholar]
22. WHO 2010 Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 354 2010 Global Report on Surveillance and Response 355 WHO/HTM/TB/2010.3 http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf?ua=1
    [Google Scholar]
23. WHO 2011) Noncommercial Culture and Drug-Susceptibility Testing Methods for Screening Patients at Risk for Multidrug-Resistant Tuberculosis (2011). Policy Statement http://www.who.int/tb/publications/2011/mdr_tb_diagnostics_9789241501620/en/
    [Google Scholar]
24. WHO 2012 Global Tuberculosis Report WHO/HTM/TB/2012.6 http://www.who.int/tb/publications/global_report/gtbr12_main.pdf
    [Google Scholar]